Ben Luft (SUNY-SB), at the 1998 FDA committee meeting on LYMErix (These references are all in the charge sheets) 1) Ben Luft said it at the 1998 FDA meeting: http://www.fda.gov/ohrms/dockets/ac/98/transcpt/3422t1.rtf BEN LUFT: “The point that I wanted to make in regard to the study is that there is very heavy dependence on serologic confirmation. And…

I think this is the one instance we all would be better off having one-dimensional thinking: How did OspA alone cause the same “multi-system” (Persing and Schoen) disease that is “indistinguishable” from what we call “Late Neurological Lyme?” What does “Great Imitator” really mean? Does this phenomenon of injecting fungal antigens that causes post-sepsis-like outcomes…

Today is the 14th of December 2017, and no one in the Government or HHS.gov has ever answered the question, What is OspA?  No reply from aaas.org either, one day later.   How does anyone expect the government to “lead” or “protect” us when they dont care what words mean, or simple chemical compounds are.  And…